Number of the records: 1
ACE inhibítory
SYS d000806 LBL 00000cz--a2200000n--4500 005 20250606214256.0 008 920504|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 $d BA006 $d BA006 $d BA006 $d BA006 065 $a D27.505.519.389.745.085 066 $a 01 $c 03 150 $a ACE inhibítory $x AD $x AE $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a ACE Inhibitor $2 eng 450 $w v $a ACE Inhibitors $2 eng 450 $w v $a Angiotensin Converting Enzyme Inhibitor $2 eng 450 $w v $a Angiotensin-Converting Enzyme Inhibitor $2 eng 450 $w v $a Angiotensin I-Converting Enzyme Inhibitor $2 eng 450 $w v $a Kininase II Inhibitor $2 eng 450 $w v $a Kininase II Inhibitors $2 eng 450 $w v $a inhibítory enzýmu konvertujúceho angiotenzín $2 slo 450 $w v $a ACE inhibítor $2 slo 450 $w v $a inhibítor angiotenzín konvertujúceho enzýmu $2 slo 450 $w v $a inhibítory angiotenzín konvertujúceho enzýmu $2 slo 450 $w v $a antagonisty enzýmu konvertujúceho angiotenzín $2 slo 450 $w v $a antagonisty kininázy II $2 slo 450 $w v $a inhibítor kininázy II $2 slo 450 $w v $a inhibítory kininázy II $2 slo 450 $w v $a inhibítor angiotenzín I-konvertujúceho enzýmu $2 slo 450 $w v $a inhibítory angiotenzín I-konvertujúceho enzýmu $2 slo 450 $w v $a antagonisty angiotenzín-konvertujúceho enzýmu $2 slo 550 $7 sllk_us_auth*d000959 $Y Antihypertensive Agents $w b $a antihypertenzíva 550 $7 sllk_us_auth*d012084 $Y Renin-Angiotensin System $w b $a systém renín-angiotenzín 550 $7 sllk_us_auth*d047228 $Y Angiotensin II Type 1 Receptor Blockers $w b $a blokátory 1. typu receptorov angiotenzínu II 665 $a 88; ANGIOTENSIN I-CONVERTING ENZYME INHIBITOR was see TEPROTIDE 1991-93 $2 eng 665 $a Enzyme Inhibitors (1975-1987) $2 eng 665 $a Enzymes/antagonists & inhibitors (1968-1974) $2 eng 665 $a Kininase II/antagonists & inhibitors (1973-1987) $2 eng 680 9-
$i A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. $2 eng 750 -2
$a Angiotensin-Converting Enzyme Inhibitors $2 eng 980 $x M
Number of the records: 1